倍輕鬆(688793.SH):公司推出訂閱制睡眠改善計劃
格隆匯5月20日丨倍輕鬆(688793.SH)在互動平臺表示,針對日益增長的睡眠經濟需求,公司構建“硬件+內容+服務”三位一體的解決方案: (1)硬件方面:智能硬件模塊搭載微型生物傳感器,可連續監測心率變異性(HRV)、體表溫度及睡眠週期,通過AI 算法生成個性化睡眠報告,且該模塊可以在各類智能穿戴設備複用; (2)內容方面:沉浸式睡眠音樂系統突破傳統白噪音技術,基於腦電波反饋動態調整聲場頻率,並與外部冥想平臺合作開發原創音療內容; (3)服務方面:結合硬件數據與雲端健康模型,公司推出訂閱制睡眠改善計劃,形成從監測到幹預的完整服務鏈。 該閉環實現從監測到幹預的完整鏈條,有望進一步爲公司帶來差異化競爭優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.